Credit Suisse’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-19
| Closed | – | – | 4345 |
|
|
2022
Q2 | $0 | Buy |
+19
| New | – | ﹤0.01% | 4386 |
|
|
2015
Q3 | – | Sell |
-860
| Closed | -$543K | – | 4174 |
|
|
2015
Q2 | $543K | Buy |
860
+756
| +727% | +$477K | ﹤0.01% | 3394 |
|
|
2015
Q1 | $53K | Sell |
104
-488
| -82% | -$249K | ﹤0.01% | 3995 |
|
|
2014
Q4 | $317K | Buy |
592
+467
| +374% | +$250K | ﹤0.01% | 3655 |
|
|
2014
Q3 | $188K | Buy |
125
+35
| +39% | +$52.6K | ﹤0.01% | 3758 |
|
|
2014
Q2 | $124K | Sell |
90
-295
| -77% | -$406K | ﹤0.01% | 4073 |
|
|
2014
Q1 | $535K | Sell |
385
-13
| -3% | -$18.1K | ﹤0.01% | 3298 |
|
|
2013
Q4 | $395K | Buy |
398
+145
| +57% | +$144K | ﹤0.01% | 3475 |
|
|
2013
Q3 | $265K | Sell |
253
-29
| -10% | -$30.4K | ﹤0.01% | 3423 |
|
|
2013
Q2 | $306K | Buy |
+282
| New | +$306K | ﹤0.01% | 3228 |
|